Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

M

Mahidol University

Status

Completed

Conditions

COVID-19

Study type

Observational

Funder types

Other

Identifiers

NCT05328479
769/2564(IRB1)

Details and patient eligibility

About

The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.

Full description

The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.

Enrollment

5,181 patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.
  2. Thai nationality, able to read and write Thai language
  3. able to use telephone and line to communicate

Exclusion criteria

  1. people who received additional vaccination after leaving quarantine before the day of the immunization test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems